Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06539624 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

Name: Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease — clinical trial record (NCT06539624)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorThe Children's Hospital of Zhejiang University School of Medicine

Started2024-10-16

View on ClinicalTrials.gov ↗

Amendment history

2026-02-25

Study Status, IPDSharing v2

Re-verified, no change to tracked fields

2024-10-28

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2024-08→confirmed 2024-10-16

Study sitesdetails revised at 2 of 2 sites

2024-08-01

Original filing

The Children's Hospital of Zhejiang University School of Medicine

58 trials monitored

See all monitored trials

Objective: To explore the safety and tolerability of different doses of EXG110 with Fabre disease

Trial Details

NCT Number	NCT06539624
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine
Conditions	Fabry Disease
Enrollment	12 participants
Start Date	2024-10-16
Primary Completion	2027-04-09 (estimated)
Study Completion	2027-04-09 (estimated)
Updated on ClinicalTrials.gov	2026-02-27